CCL20 and cervical cancer: Th17 cells can be recruited to the TIME via the CCR6-CCL20 pathway in cervical cancer due to upregulated CCL20 in tumor tissues and high expression of CCR6 on Th17 cells aggregated within tumor tissues (113).